Clinical Experience With IV Angiotensin II Administration: A Systematic Review of Safety

OBJECTIVE: Angiotensin II is an endogenous hormone with vasopressor and endocrine activities. This is a systematic review of the safety of IV angiotensin II. DATA SOURCES: PubMed, Medline, Scopus, and Cochrane. STUDY SELECTION: Studies in which human subjects received IV angiotensin II were selected...

Descripción completa

Detalles Bibliográficos
Autores principales: Busse, Laurence W., Wang, Xueyuan Shelly, Chalikonda, Divya M., Finkel, Kevin W., Khanna, Ashish K., Szerlip, Harold M., Yoo, David, Dana, Sharon L., Chawla, Lakhmir S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2017
Materias:
Feature Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5515638/
https://www.ncbi.nlm.nih.gov/pubmed/28489648
http://dx.doi.org/10.1097/CCM.0000000000002441

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5515638/
https://www.ncbi.nlm.nih.gov/pubmed/28489648
http://dx.doi.org/10.1097/CCM.0000000000002441

Ejemplares similares